Stage IV pancreatic cancer tissues showed even higher levels of GFRAL expression than stage I. In addition, Kaplan–Meier analysis has shown that higher levels of GFRAL expression are associated with lower 5-year overall survival rates in patients. The gene discussed is GFRAL; the disease is familial pancreatic carcinoma.